• What we do

    What we do +

    Bringing cloud based infrastructure, scientific expertise and full service to support the optimal design and efficient management of clinical trials, where imaging provides critical evidence of the novel compound safety and efficacy.

    Expertise

    Expertise +

    Trial design, regulatory and financial strategy for biotechnology companies involved in clinical research of immuno-oncology, inflammatory and degenerative diseases.

    Therapeutic Experts

    Therapeutic Experts +

    Passionate, science driven, agile team, working in close partnership with leading clinicians and imaging leaders to deliver operational, strategic and partnering support to biotech and pharma clients.

    Cloud Trial Platform

    Cloud Trial Platform +

    Dynamika is used by bio- pharmaceutical companies and academic investigators to improve image logistics, automate image quality assurance, and standardize advanced imaging data analysis.

  • Trial Services

    Trial Services +

    We deliver accurate and comprehensive image analytics and provide full support of early phase trials and R&D studies crucial to make go / no-go decision on further development of the compound.

    Therapeutic Areas

    Therapeutic Areas +

    We deliver the most comprehensive set of imaging markers and ensure that Sponsors and Investigators are fully informed of the treatment profile when making a decision on the success of the compound.

    Clinical Trial Team

    Clinical Trial Team +

    Dedicated team of clinical and radiology experts, software engineers and algorithm developers will be engaged to deliver bespoke end-to-end support for your imaging study.

    Expertise

    Expertise +

    Trial design, regulatory and financial strategy for biotechnology companies involved in clinical research of immuno-oncology, inflammatory and degenerative diseases.

  • Why Dynamika

    Why Dynamika +

    Delivering your study on budget and on time with the cloud based infrastructure, patented scoring methodologies for advanced imaging and a network of therapeutic and imaging experts.

    Case Studies

    Case Studies +

    Case studies and clinical routine examples of using advanced imaging and quantitative image markers for highly efficient interpretation and management of imaging data

    Dynamika for Research

    Dynamika for Research +

    Dynamika is the best link between cutting academic research and clinical trial word. We ensure that you benefit from the latest science delivered within standardized regulated environment

    Cloud Trial Platform

    Cloud Trial Platform +

    Dynamika is used by bio- pharmaceutical companies and academic investigators to improve image logistics, automate image quality assurance, and standardize advanced imaging data analysis.

  • Connect



    DYNAMIKA QUESTIONS:
    E: dynamika@imageanalysis.org.uk
    T: + 44 7413 022053

    PROJECT SUPPORT:
    E: support@imageanalysisgroup.com

    UK: +44 7413 022053

    USA: + 1 6177 523561



    Discuss your Study (Europe)

    T: + 44 7413 022053
    E: contact@imageanalysisgroup.com

    QABC Minster House, 272-274 Vauxhall Bridge Road, London, SW1V 1BA United Kingdom

    Discuss your Study (United States)

    T: + 1 6177 523561
    E: contact@imageanalysisgroup.com

    800 Boylston St, Boston, MA 02199, USA

Company News

IA Announce FDA 510(k) Clearance for Dynamika Platform and a New Release with Advanced Imaging and RECIST Scoring

Image Analysis Group (IA-Group), expert imaging clinical research organization are pleased to announce FDA (U.S. Food and Drug Administration) 510(k) clearance of their proprietary cloud-based software platform DYNAMIKA. DYNAMIKA is a powerful cloud platform for management, review and automated scoring of imaging data in clinical trials. It has been cleared by the FDA for the display, analysis [...]

IA’s team at ASCO annual meeting on June 2–6, 2017, at McCormick Place, Chicago

Meet IA’s team at the American Society of Clinical Oncology (ASCO) annual meeting on June 2–6, 2017, at McCormick Place, Chicago. The group’s CEO, Dr. Olga Kubassova and Head of R&D, Dr. Diana Roettger will be attending the meeting to present and discuss the Company’s work in oncology and immuno-oncology. In particular, the use of advanced [...]

Meet IA-Group Research Team at OARSI to Discuss Osteoarthritis Clinical Research

Meet IA’s musculoskeletal experts at the World Congress on Osteoarthritis in Las Vegas, NV, April 27-30, 2017, where they will be speaking about their work in osteoarthritis clinical research. Dr. John Carrino, member of IA’s Clinical Advisory Board will speak at 12:00 on 30 April in a Plenary Session ‘Year in Review’ and give an [...]

View all news

Blog

Drug Development in Osteoarthritis

Despite millions of sufferers around the world and the market valued at over $3.5 billion a year, osteoarthritis treatment still largely relies on cheap generic drugs. Only a few companies have disease-modifying biologic drugs at the late stage of development. Among them: Tissuegene, Nordic Biosciences / Merck and Seikagaku. Several others are developing drugs for [...]

Immuno-Oncology and the Need to Review Drug Development

By Diana Roettger, PhD Head of R&D Immuno-Oncology drugs are considered as a breakthrough in cancer treatment because of their ability to target and enable immune cells to destroy cancer cells. Immunotherapies force us not only to review cancer treatment but also drug development. The immune system is the body’s natural defence system, attacking dangerous [...]

Muscle Perfusion as a Unique Biomarker for in Clinical Trials

Skeletal muscle can adapt to various stimuli. Physical activity and exercise represent different types of stresses to the muscle. Depending on the exact nature of the stress, muscle may increase in size, improve neuro-muscular performance and enhance endurance capabilities. This brief overview gives an introduction into the clinical research conducted by IA-Group and collaborators into [...]

View more posts

Latest Tweets

RT @vRad: Report says CAD will dominate #imaging market for next 5 years due to #mammography & #MRI applications http://t.co/Divka2CZWx

RT @BioMedCentral: RT @stefaniealaimo: #MRI detects early effects of #chemotherapy on children’s hearts from @BioMedCentral blog http://t.c…

RT @OlgaKubassova: #Mammography has not reduced deaths from #breast cancer. Real need for effective #imaging for early detection - #MRI htt…

RT @OlgaKubassova: Early Treatment Start Key to RA Remission http://t.co/3AhJWLvqOB

Market growth & overview of #imageanalysis #software market driven by demand for diagnostic procedures & #technology http://t.co/wHoi0He0cL

@sarahhowardview @downingstreet brilliantly :) great event for #smallbusiness and #innovation driven enterprisers http://t.co/wJWvy5bmOe

RT @jemilad: Great talk by @OlgaKubassova on how @ImageAnalysisUK delivers objectivity, efficiency and precision in medical image analysis …